Elevance Health Inc (ELV) Actualités

Form 8-K - Current report

Elevance Health Reports Second Quarter 2024 Results

2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain1 of $2.8 billion 2Q 2024 diluted EPS2 of $9.85, up 26%; adjusted...

Elevance Health Releases Impact Report

Elevance Health released its annual Impact Report, highlighting its continued evolution from a traditional health insurance benefits company to a...

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024

Elevance Health (NYSE: ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”...

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Form 8-K - Current report

Form 8-K - Current report

Elevance Health Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference

Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Elevance Health Announces Appearance at Bernstein’s 40th Annual Strategic Decisions Conference

Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities